Figure 3From: P38 MAP Kinase inhibition promotes primary tumour growth via VEGF independent mechanismTumour volumes over time in response to treatment with control and SB-202190 treated animals. Animals (n = 10, per group) were randomised to receive control (vehicle) or SB-202190 (2.5 μM/kg) via an intraperitoneal route on a daily basis. (* = p < 0.05).Back to article page